SHENZHEN, China, Jan. 23 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com the company is pleased to announce the launch its cosmetics products line on the Internet. The cosmetics company also located in E Europe (Serbia) is engaged in online sales of the "Melem" product. Melem is a versatile, all-purpose skin and lip balm. It has a wide variety of skin and lip problems including eczema, psoriasis, chapped skin and lips, calluses, sunburns, insect bites and much more. The domain name of the Melem on line store is http://www.melemsecret.com
Andrea Rubio Zecevic, who currently acts as a head scientific advisor to HTDS said "Just to be clear, as this is worth repeating the Melem cosmetics company is not the core business of HTDS by any stretch of the imagination. It's a small division manned by a couple of staff. Simply put it is a self supporting cosmetics company and a nice add on for HTDS. I would characterize it as a feel good division of HTDS. The bulk of our revenue will be derived from our soon to be merged Mellow Hope Biological Vaccines company"
Mellow Hope is China based and the biggest exporter of Biological Vaccines in China. It has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; Blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestatin.
Mellow Hope revenues are currently in excess of $15 million USD, and growing.
The company will provide further details as they become available.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.
CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at [email protected]
For any corporate matters the readers should contact the company directly at [email protected]
SOURCE Hard to Treat Diseases